Who should receive LAIs? Consider LAIs for patients with recent-onset schizophrenia and those with risk factors for medication nonadherence: history of non-adherence, severe symptoms, comorbid substance use, cognitive impairment, ambivalence or negative attitudes towards medications, and poor insight. Are the newer LAIs more effective? The effectiveness of newer LAIs (aripiprazole, olanzapine, paliperidone […]